Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients
一项针对预防卵巢癌和子宫内膜癌患者复发的叶酸结合蛋白衍生E39肽疫苗的I/IIa期试验的最终分析
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.2378
Brown, Tommy A; Byrd, Kevin; Vreeland, Timothy J; Clifton, Guy T; Jackson, Doreen O; Hale, Diane F; Herbert, Garth S; Myers, John W; Greene, Julia M; Berry, John S; Martin, Jonathan; Elkas, John C; Conrads, Thomas P; Darcy, Kathleen M; Hamilton, Chad A; Maxwel, George L; Peoples, George E
